Skip to main content
Premium Trial:

Request an Annual Quote

Bass Group Buys Stake in Human Genome Sciences

Premium

ROCKVILLE, Md.--A group of investors including several members of the Bass family purchased a 14 percent stake in the genetic research firm Human Genome Sciences here this summer, according to a filing made last month with the Securities and Exchange Commission. The filing showed that between June 8 and August 8, the group bought 568,000 shares at prices ranging from $30.42 to $31.02 per share, for investment purposes. Human Genome Sciences is involved in the discovery of human and microbial genes for the prevention, detection, treatment, and cure of disease. The firm develops products both on its own and in partnership with other companies.

Filed under